ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
0.6120
-0.0110 (-1.77%)
At close: Apr 1, 2025, 4:00 PM
0.6080
-0.0040 (-0.65%)
After-hours: Apr 1, 2025, 7:24 PM EDT

ALX Oncology Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
33887424598703,435
Upgrade
Market Cap Growth
-88.13%-88.13%61.50%-47.23%-74.66%-
Upgrade
Enterprise Value
-79-435671814883,181
Upgrade
Last Close Price
0.621.6714.8911.2721.4986.20
Upgrade
PS Ratio
----2905.75
Upgrade
PB Ratio
0.290.783.911.742.407.99
Upgrade
P/TBV Ratio
0.780.783.911.742.407.99
Upgrade
EV/Sales Ratio
----2691.10
Upgrade
Debt / Equity Ratio
0.150.150.050.040.00-
Upgrade
Asset Turnover
-----0.01
Upgrade
Quick Ratio
6.956.955.109.4023.7869.99
Upgrade
Current Ratio
7.267.265.249.5724.0070.28
Upgrade
Return on Equity (ROE)
-88.91%-88.91%-70.97%-39.42%-21.05%-21.30%
Upgrade
Return on Assets (ROA)
-45.62%-45.62%-38.77%-23.20%-12.80%-12.22%
Upgrade
Return on Capital (ROIC)
-53.97%-53.97%-45.07%-25.02%-13.16%-12.55%
Upgrade
Earnings Yield
-420.93%-153.10%-21.68%-26.88%-9.59%-1.33%
Upgrade
FCF Yield
-381.94%-138.92%-17.75%-19.74%-7.90%-1.12%
Upgrade
Buyback Yield / Dilution
-21.37%-21.37%-5.62%-0.97%-118.05%-500.86%
Upgrade
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q